Sponsored content: CHI Pharma launches Alieve pain relief range in Nigeria

Sponsored content: CHI Pharmaceuticals launches Alieve, a new ibuprofen-based pain relief brand targeting everyday Nigerian consumers. The product line includes three NAFDAC-registered formulations: 100 mg/5 mL oral suspension for children, and 200 mg and 400 mg tablets for adults.

The campaign centers on "Man No Be Machine" — acknowledging that Nigerians push through demanding schedules but still need relief when headache, body ache, or fever hits. TGI Group's CMO Probal Bhattacharya frames Alieve as a "caring companion" helping hardworking people return to their routines.

Pricing and specific retail availability were not disclosed in the announcement. The brand positions itself alongside established OTC pain relievers in a market where self-medication for common ailments is widespread.

For consumers evaluating options: Alieve adds another ibuprofen choice to pharmacy shelves. Will you try a new brand backed by CHI Pharma's portfolio, or stick with established pain relievers you already trust?

SOURCE: https://dailypost.ng/2026/10/28/man-no-be-machine-alieve-relieves-everyday-pain/